Revenue Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Health segment Revenue | 1.4B | 1.49B | 1.48B | 1.51B | 14.26B | 1.46B | 1.49B | 1.23B | 1.37B | 1.47B | 1.48B | 1.26B | 1.42B | 1.47B | 1.42B | 1.17B | 1.22B | 1.1B | 1.21B | 1.12B | 1.12B | 1.12B | 1.02B | 1.04B | 1.02B | 1.09B | 8.92B | 9.29B | 9.16B | 8.76B | 8.19B | 8.9B | 9.44B | 8.7B | 8.1B | 9.03B | 8.93B | 8.56B | 8.27B | 9.37B | 9.13B | 9.09B | 8.45B |
| Animal Health segment Revenue Growth | -6.05% | +0.34% | -1.92% | -89.41% | +879.60% | -2.35% | +21.22% | -10.28% | -6.54% | -1.01% | +17.53% | -11.01% | -3.74% | +3.81% | +21.40% | -4.26% | +10.81% | -9.31% | +8.20% | 0.00% | -0.18% | +9.66% | -1.06% | +1.47% | -6.33% | -87.78% | -3.99% | +1.46% | +4.53% | +7.01% | -8.08% | -5.71% | +8.54% | +7.35% | -10.22% | +1.14% | +4.22% | +3.61% | -11.78% | +2.58% | +0.52% | +7.53% | n/a |
| Pharmaceutical segment Revenue | 14.04B | 14.94B | 14.41B | 14.01B | 1.4B | 13.46B | 12.72B | 12.18B | 12.96B | 12.76B | 14.11B | 10.6B | 11.5B | 9.98B | 10.68B | 11.37B | 11.32B | 9.68B | 10.65B | 10.53B | 11.1B | 10.46B | 9.66B | 9.83B | 9.66B | 9.28B | 1.06B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pharmaceutical segment Revenue Growth | -6.02% | +3.71% | +2.87% | +900.43% | -89.60% | +5.79% | +4.45% | -6.05% | +1.62% | -9.58% | +33.05% | -7.77% | +15.19% | -6.51% | -6.09% | +0.42% | +16.95% | -9.16% | +1.16% | -5.07% | +6.07% | +8.25% | -1.70% | +1.78% | +4.05% | +771.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Quarter | Dec 31, 2024 | Dec 30, 2023 | Dec 30, 2022 | Dec 30, 2021 | Dec 30, 2020 | Dec 30, 2019 | Dec 30, 2018 | Dec 30, 2017 | Dec 30, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 11.83B | 3.23B | 3.61B | 2.41B | 2.86B | 2.94B | 2.91B | 4.34B | 3.92B | 6.49B | 7.42B | 7.89B | 20.39B | 20.5B | 20.23B |
| Asia Pacific Revenue Growth | +266.88% | -10.76% | +50.15% | -15.96% | -2.68% | +1.17% | -32.93% | +10.69% | -39.66% | -12.52% | -5.92% | -61.31% | -0.50% | +1.33% | n/a |
| Emea Revenue | 14.04B | 3.09B | 2.58B | 2.21B | 2.27B | 2.47B | 2.42B | 2.34B | 2.15B | 10.68B | 13.17B | 13.14B | 12.99B | 4.83B | 13.5B |
| Emea Revenue Growth | +354.99% | +19.52% | +17.04% | -2.99% | -7.90% | +2.24% | +3.25% | +8.54% | -79.82% | -18.95% | +0.26% | +1.15% | +168.67% | -64.18% | n/a |
| Latin America Revenue | 3.46B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.82B | 3.15B | 3.2B | 5.1B | n/a | 3.77B |
| Latin America Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.41% | -1.62% | -37.22% | n/a | n/a | n/a |
| United States Revenue | 32.28B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.52B | 17.07B | 18.25B | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +2.62% | -6.44% | n/a | n/a | n/a | n/a |